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Abstract Solubilized ~2sI-¢o conotoxin MVIIC receptors from 
rat cerebellum were immunoprecipitated by antibodies directed 
against the calcium channel ~IA subunit. Anti-alA antibodies 
recognized a 240-220, 180 and 160 kDa proteins in immunoblots 
of cerebellar membranes. Disuccinimidyl suberate cross-linked 
~2sI-~o conotoxin MVIIC to an ct26-1ike 200-180 kDa subunit, 
which migrated at 150-140 kDa after disulfide reduction. These 
observations are consistent with a heteromeric structure in which 
high affinity to conotoxin MVIIC binding sites formed by a lA  
subunits are located in close proximity to peripheral ct2 subunits. 
Key words: Calcium channel; (o conotoxin MVI IC receptor; 
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1. Introduction 
Voltage gated calcium channels in neurons have been classi- 
fied as L, N, P, Q and T type, on the basis of their electrophys- 
iological and pharmacological properties [1-3]. Calcium chan- 
nels contain a pore-forming ~1 subunit hat carries binding sites 
for channel blockers, and is generally associated with periph- 
eral ~2J and fl subunits [4-6]. A family of cDNAs encoding 
homologous c~l (A, B, C, D, and E) subunits have been isolated 
from neuronal ibraries [7,8], Important aims at present are to 
establish a correlation between calcium channel antagonist 
binding sites expressed in the brain and a given class of a l 
subunit and to examine the polypeptide composition of the 
different calcium channel classes expressed in the brain. 
Specific neurotoxins are powerful tools in this field. For 
example irreversible block by to conotoxin GVIA (o)GVIA) 
from the marine mollusc Conus geographus [9], is a property 
unique to N-type channels and coGVIA receptor sites were 
subsequently shown to be associated with the c~lB subunit in 
the brain [5,6,10] and in heterologous expression systems [11]. 
A structurally related peptide from Conus magus, co conotoxin 
MVI IC (o)MVIIC), blocks a population of o)GVIA-insensitive 
calcium channels that are expressed in both the soma and 
synaptic terminals of central neurones [3,12,13]. Binding studies 
with rat brain membranes indicate that o)MVIIC and toGVIA 
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have distinct receptor sites [12,14]. Expression of the ~IA sub- 
unit in Xenopus oocytes supports calcium currents that display 
sensitivity to sub-micromolar concentrations of (oMVIIC [15], 
however little is known about the polypeptide composition of 
the native calcium channels in the mammalian brain that consti- 
tute high affinity (oMVIIC receptors. In the present study we 
have used affinity labeling methods and sequence directed anti- 
c~l antibodies to address this question. 
2. Experimental 
2.1. Materials 
Synthetic c0MVIIC was obtained from Bachem (Bubendorf), 
coGVIA from the Peptide Institute (Osaka), and disuccinimidyl suber- 
ate (DSS) from Pierce (Interchim, France). Protein A Sepharose CL4B 
was from Sigma (St. Louis MO) and N-glycosidase F from Boehringer 
(Mannheim), 
2.2. Membrane preparations 
Cerebella or cerebra from one-month-old Wistar rats were dissected 
and homogeneized in a glass/teflon Thomas apparatus in a 0.32 M 
sucrose, 10 mM HEPES buffer adjusted to pH 7.4 with NaOH, in the 
presence of a mixture of protease inhibitors: 0.2 mM phenylmethylsul- 
fonyl fluoride, 1 mM iodoacetamide, 2/zM pepstatin A, 1 mM EDTA, 
2/zM leupeptine, 0.15/~M aprotinine, and 2 mM benzamidine. After 
a 10 min centrifugation at800 x g, the supernatant was recovered and 
spun at 27,000 x g for 40 min. Protein was assayed by the BCA method 
(Pierce) using a BSA standard. 
2.3. Conotoxin iodination and binding experiments 
Preparation and binding of mono[~ZsI]-iodo mGVIA were performed 
as previously described [16,17]. Mono[125I]-iodo o)MVIIC was prepared 
by the iodogen method using Na~25I (New England Nuclear 2,000 
Ci/mmol) and purified by HPLC on an analytical C18 column (Beck- 
mann) [12]. The binding of IzsI-(oMVIIC to synaptosomal membranes 
was measured at 30°C in 100 ~1 Tris-buffered saline: 150 mM NaC1, 
25 mM Tris base adjusted to pH 7.4 (TBS), containing 0.1% BSA. 
Binding was initiated by addition of 20 /~g of membrane protein, 
stopped by rapid filtration on glass fiber filters (GFC-Whatman) pre- 
treated with 0.3% polyethyleneimine and washed three times with 2 ml 
of ice-cold TBS containing 0.1% BSA, 1,5 mM CaC12, 0.05% 
Tween-20. 
2.4. Affinity labeling 
Synaptosomes (300/~g) were incubated for 2 h at 4°C with 1 nM 
~251-o)MVlIC in the presence or absence of 1 ~M unlabeled c0MVIIC 
in 300/zl of 20 mM HEPES, 0.15 M NaC1, adjusted to pH 8.3 with 
NaOH. DSS solubilized in dimethylsulfoxide was added to a final 
concentration f 30/IM, and the mixture was incubated for 20 min at 
20°C. The synaptosomes were sedimented, washed once with 20 mM 
HEPES, 0.15 M NaCI, 10 mM CaC12 adjusted to pH 8.3 with NaOH, 
and once with the same buffer from which CaCI_, was omitted. Synap- 
tosomes were again incubated with 1 nM '25I-coMVIIC and the cycle 
repeated as described above. The labelled membranes were processed 
for electrophoresis a described below. 
2.5. Preparation of antibodies 
Polyclonal antisera were produced in rabbits using synthetic peptides 
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selected from calcium channel ~l sequences, coupled to keyhole limpet 
hemocyanin. RbA-1 antibodies were raised against he peptide (C)PS- 
SPERAPGREGPYGRE, and rbA-2 antibodies against the peptide 
LRQTARPRESARDPDA corresponding to residues 865 881 and 
845 860, respectively from the rat brain colA sequence [18]. Antisera 
were raised against peptides from the two alternative C-terminal re- 
gions of the rabbit brain sequence BI [19], BI-I antibodies against he 
peptide (C)RDQRWSRSPSEGRQHTTHRQ and BI-2 antibodies 
against the peptide (C)GGRRWTASAGKGGGGPRASA, corre- 
sponding to BI-1 residues 2,254-2,273 and BI-2 residues 2,402-2,421 
respectively. IgG were purified by affinity chromatography onprotein 
A-Sepharose CL4B. 
2.6. hnmunoprecipitation 
Membranes were incubated with 0.5 nM ]25I-c0MVIIC overnight at 
4°C in binding buffer, pelleted at 10,000 × g for 10 rain, and solubilized 
in 1% CHAPS in buffer A (0.32 M sucrose, 10 mM HEPES adjusted 
to pH 7.4). Protein A-Sepharose CL4B was swollen in TBS containing 
0.5% BSA and incubated with antibodies for 1 h at 4°C. Following 
centrifugation, the pellet was washed with 0.4% CHAPS in buffer A and 
solubilized membrane proteins containing 3fmol of toMVIIC receptor 
were added in a final volume of 100/zl and incubated for 3 h at 4°C. 
The pellet was washed once with TBS, 0.5% BSA, and the immunopre- 
cipitated radioactivity was counted. 
2. 7. Electrophoresis and Western blotting 
Proteins were denatured at room temperature for 30 min in 3% SDS, 
6% sucrose, in 70 mM Tris-HC1 at pH 8.9, in the presence or absence 
of 25 mM dithiothreitol. Iodoacetamide was then added to a final 
concentration f 80 mM. SDS-PAGE was performed on 5-12% gradi- 
ent gels. Proteins were transferred to nitrocellulose membranes 
(Hybond, Amersham) at 100 mA overnight. The membrane was 
blocked for 2 h at room temperature with 10% dried milk in TBS and 
then incubated with antibodies (50/zg/ml) in blocking buffer at 4°C 
overnight. After extensive washing in 0.05% Tween-20 TBS, detection 
was performed with anti-IgG peroxidase and the ECL system (Amer- 
sham). 
2.8. Deglycosylation 
Affinity-labeled protein bands were electroeluted from SDS gels in 
50 mM Tris, 0.1% SDS, 0.38 M glycine adjusted to pH 8.8 with HCI, 
diluted five-fold in 0.1 M NaP~, 0.1% SDS, 0.5% CHAPS, 10 mM 
EDTA, 1% fl-mercaptoethanol, pH 8, and concentrated on Ultrafree 
TTK24 (Millipore) membranes. N-glycosidase F (2 units) was added 
and incubated for 24 h at 37°C. Proteins were denatured and separated 
by SDS PAGE as described. 
3. Resu l t s  and  d iscuss ion  
3.1. 1251-co conotoxin MVI IC  binding to cerebellar membranes 
Specific binding of 0.5 nM n25I-coMVIIC to cerebellar mem- 
branes reached equilibrium in about 30 min at 30°C and pH 
7.4 (Fig. I A). In these conditions non-specific binding deter- 
mined in the presence of 0.1 ~M unlabeled mMVIIC, accounted 
for approximately 50% of the total bound radioactivity. The 
addition at equilibrium of a large excess of unlabeled coMVIIC 
initiated issociation with 50% release occuring at about 10 min 
(Fig. 1B). Semi-logarithmic plots of the association and dissoci- 
ation kinetics (insets to Fig. 1A,B) allowed measurement of the 
apparent association rate constant  (kapp) = 7.7 × 10 -4 s - I  and 
the dissociation rate constant (k_]) = 5.5 x 10 -4 s ~, and subse- 
quent calculation of the association rate constant k] = 0.5 x 10 6 
s -~. M-L The equilibrium dissociation constant was therefore 
(KD--k_]/kO = 1.8 nM, which was in good agreement with 
results obtained from displacement of ~251-mMVIIC by unla- 
beled ogMVIIC (KD = 1 nM) at equilibrium (not shown). Direct 
receptor saturation experiments were not performed. However 
from experiments carried out with a ligand concentration = KD, 
a total receptor capacity of approximately 0.9 pmol/mg protein 
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Fig. 1. Binding kinetics of ]251-O) conotoxin MVIIC to rat cerebellar 
membranes. (A) Association kinetics: membranes were incubated for 
the indicated time with 0.5 nM '25I-coMVIIC, in the presence (non- 
specific binding) or absence (total binding) of 0.3 /tM unlabeled 
¢oMVIIC. The specific binding component was determined by subtrac- 
tion. B, Dissociation kinetics: at equilibrium, unlabeled ¢0MVIIC was 
added to obtain a final concentration f 0.3/zM and initiate release. The 
remaining specifically bound radioactivity was then measured at the 
indicated times. Insets A and B: linear semi-logarithmic plots. B = spe- 
cifically bound, Beq = specifically bound at equilibrium. 
in cerebellar synaptosomes and 0.4 pmol/mg protein in cerebral 
synaptosomes was estimated. ~25I-mMVIIC binding was not 
displaced by unlabeled mGVIA, or 09 agatoxin IVA (mAgaIVA) 
but was inhibited by Ca 2+ with a K~ < 1 mM (Table 1). 
3.2. Immunoprecipitation f  o3 conotoxin MVI IC  receptors 
RbA-1 antibodies were raised against a peptide from the 
cytoplasmic loop between domains II and III that is specific to 
the rat brain ~IA  subunit sequence [18]. The ability of these 
antibodies to recognize the toMVIIC receptor was tested. The 
addition of protein A-Sepharose CL4B beads coated with in- 
creasing amounts of rbA-1 antibodies to CHAPS solubilized 
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~25I-ogMVIIC receptors resulted in concentration-dependent 
immunoprecipitation (Fig. 2A). After subtraction of back- 
ground precipitation determined with non-immune rabbit IgG, 
approximately 50% ofmMVIIC receptors were specifically rec- 
ognized at the plateau level. Immunoprecipitation was shown 
to be specific by two other criteria: block of recognition by the 
synthetic peptide used to raise rbA-1 antibodies, and lack of 
immunoprecipitation of solubilized 125I-ogGVIA receptors (Fig. 
2B). These results indicate that high affinity receptors for 
t25I-mMVIIC are associated with the cdA subunit. 
BI-1 and BI-2 antibodies were designed to distinguish be- 
tween two 0~lA splice variants expressed in rabbit brain that 
contain alternative C-terminal segments [19]. The peptide used 
to raise BI-1 displayed 85% identity with the rat brain c~lA 
C-terminus [18]. Specific immunoprecipitation of about 15% of 
125I-coMVIIC receptors was achieved with BI-1 antibody, but 
no reaction was detected with the BI-2 antibody (Fig. 2B). 
Some of the c~ 1A subunits that constitute the ogMVIIC sensitive 
calcium channel in the cerebellum thus contain the variant BI-1 
C-terminus. 
3.3. Detection of t~IA polypeptides by immunoblotting 
In order to detect he ~IA subunits expressed in the brain, 
immunoblots were probed with rbA-2 antibodies. RbA-2 anti- 
bodies were raised against a second peptide specific to the loop 
linking domains II and III of ~IA. Although this antibody 
specifically immunoprecipitated a smaller fraction (approxi- 
mately 35%) of coMVIIC sensitive calcium channels than 
rbA-l,  it was found to be more sensitive for staining of im- 
munoblots. RbA-2 reacted with several bands in cerebellar 
synaptosomes (Fig. 3, lane 1). Specificity of recognition was 
ascertained by parallel experiments in which the cognate pep- 
tide was used to block antibody binding (Fig. 3, lane 2). A 
240-220 kDa doublet that sometimes appeared as a single 
band, and two polypeptides of 180 and 160 kDa were identified, 
with the 180 kDa band producing the most intense reaction. 
Similar experiments with cerebral synaptosomes (Fig. 3, lanes 
3 and 4), produced much lower levels of immunostaining, and 
only the 180 kDa band was consistently detected. 
These results suggest hat the 240-220 kDa doublet repre- 
sents ctlA subunits whereas the 180 and 160 kDa size forms 
may result from post-translational cleavage of the larger pol- 
ypeptides. The reduction of disulfide bridges did not produce 
any change in electrophoretic mobility of these proteins (not 
shown). 
3.4. Affinity labeling 0f125I-(0 conotoxin MVIIC receptors 
A homobifunctional reagent DSS was used to crosslink 
Table 1 
Effects of neurotoxins and Ca 2÷ on ~25I-co conotoxin MVIIC binding 
Assay conditions Binding (%) 
Control 100 
0.3 pM co conotoxin GVIA 103 
0.3 pM co agatoxin IVA 93 
0.3 mM CaCL 64 
1 mM CaCI2 32 
Assays were performed with 0.5 nM ~251-COMVIIC in the presence and 
absence of 0.1 ~M unlabeled toMVIlC. Specific binding was calculated 
by subtraction and represented as a % of the control. Results are the 
mean of duplicate determinations from two independent experiments. 
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Fig. 2. Immunoprecipitation of t25I-co conotoxin MVIIC receptors. 
(A) Solubilised 125I-coMVIIC-labeled receptors were incubated with 
protein A-Sepharose CL4B beads coated with rbA-1 (triangles) or con- 
trol IgG (circles). Labeled immune complexes were recovered by cen- 
trifugation and counted. (B) Solubilised ~25I-COMVIIC receptors (solid 
125 and hatched bars) or I-COGVIA receptors (open bars) were incubated 
as in A with anti-0dA antibodies alone (solid and open bars) or after 
preincubation with the synthetic peptide used to raise the antibody 
(hatched bars). 
125I-o)MVIIC to membrane polypeptides in proximity to the 
binding site (Fig. 4). When electrophoresis was performed in 
non-reducing conditions, labeled proteins of 200 and 180 kDa 
were detected by autoradiography (Fig. 4A, lane 1). However 
after disulfide reduction with dithiothreitol (Fig. 4A, lane 2), 
these proteins migrated as a poorly resolved 150-140 kDa dou- 
blet. Labeling was blocked by the presence of 0.1 tiM (oMVIIC 
(Fig. 4A lanes 3 and 4), but not by 0.1 pM mGVIA (not shown). 
Treatment with dithiothreitol, which had no effect on the 
mobility of the immunostained c~lA polypeptides, thus appar- 
ently dissociated an unlabeled isulfide-linked polypeptide of 
40-50 kDa from both the 200 and the 180 kDa proteins. The 
change in electrophoretic mobility of these proteins upon re- 
duction is similar to that of the ct2 subunit of the skeletal muscle 
L type calcium channel, which is disulfide linked to a a polypep- 
tide, and displays extensive N-glycosylation [4]. Electroelution 
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and N-glycosidase F treatment of the proteins cross-linked to 
125I-mMVIIC confirmed the presence of N-linked carbohydrate 
and indicated a core polypeptide mass of about 100 kDa (not 
shown), which is in good agreement with the electrophoretic 
mobility of deglycosylated ~2 subunits from skeletal muscle 
calcium channels [4]. Control incubations in the absence of 
N-glycosidase F did not affect migration. Alpha 2 and d pol- 
ypeptides are encoded by a single gene [20], of which a single 
splice variant cc2b is expressed in the nervous ystem [21]. 
Two neurotoxins, o)AgaIVA and o)MVIIC, are currently 
used to dissect coGVIA-insensitive, DHP-insensitive calcium 
channel currents in central neurons and heterologous expres- 
sion systems [22]. Low nanomolar concentrations of mAgaIVA 
[23], but significantly higher concentrations of o)MVIIC [12], 
block P type channels, which are predominant in cerebellar 
Purkinje neurons. Preferential expression of class A transcripts 
in the cerebellum [18,19] has thus suggested that P type chan- 
nels contain col A subunits. However expression of cO A, ~2 and 
13 subunits in Xenopus oocytes induces currents with reversed 
sensitivity that are strongly blocked by o)MVIIC but only par- 
tially inhibited at high concentrations of o)AgalVA [15]. Subse- 
quently a native calcium current with similar properties has 
been identified in cerebellar granule cells and designated as the 
Q channel [3]. Evidence therefore suggests that ~IA subunits 
support both P and Q type channels, although little is known 
about the heteromeric composition of native channels. 
Our data suggests that high affinity coMVIIC binding sites 
in the cerebellum, which may correspond to Q type calcium 
channels, are associated with c~lA subunits. Although we have 
not directly addressed the interaction of 13-subunits with 
o)MVIIC receptors, heterologous expression of ~IA has indi- 
cated that the generation of robust currents requires co-expres- 
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Fig. 3. Immunoblot detection of ~IA subunits in rat brain membranes. 
Immunoblots of cerebellar (lanes 1 and 2) or cerebral (lanes 3 and 4) 
membranes were probed with rbA-2 antibodies alone (1,3) or with 
rbA-2 antibodies that had been preincubated with the rbA-2 peptide 
(2,4). Immunoreactive proteins were revealed by incubation with anti- 
IgG peroxidase and chemiluminescent de ection. 
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Fig. 4. Covalent cross-linking of kzsI-m conotoxln MVIIC to receptor 
associated proteins. Cerebellar membranes were incubated with t25I- 
mMVIIC in the presence (lanes 3 and 4) or in the absence (lanes 1 and 
2) of 0.1 ~M unlabeled coMVI1C. Disuccinimidyl suberate was added 
to cross-link the ligand to receptor proteins. Samples were prepared for 
SDS PAGE after alkylation (lanes 1 and 3) or after disulfide bridge 
reduction followed by alkylation (lanes 2 and 4). After SDS PAGE 
labeled polypeptides were detected by autoradiography. 
sion of a 13 subunit [15,19]. Co-expression of a fl subunit with 
the cardiac ~IC subunit has been shown to increase the binding 
affinity for dihydropyridines [24]. By analogy it is possible that 
13 subunits may play a role in defining the sensitivity of c~lA 
subunits to ogMVIIC and oJAgaIVA. 
Chemical cross-linking suggests proximity of an ~2-1ike sub- 
unit to receptor-bound coMVIIC, although conotoxin binding 
sites are thought to be formed by ~zl subunits. This is not 
without precedent as cross-linking of coGVIA to an cz2-1ike 
subunit in chick but not rat brain membranes has been reported 
[25], although the ~IB subunit is now known to constitute the 
binding site. Subtle differences in the spatial relationships of 
homologous conotoxin binding sites to the ~2 protein may 
therefore xist between different species and channel classes. 
Negative charges at the surface of these highly glycosylated 
subunits may conceivably affect the access of different oxins 
to their pharmacological sites. Consequently we may speculate 
that heterogeneity in the glycosylation of c~2 subunits may also 
be relevant to differences in the potency of mMVIIC and 
coAgaIVA in blocking P and Q type currents upported by the 
~IA subunit. 
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